Clinical Trials Browser

Recruiting × Interventional × Acquired Immunodeficiency Syndrome × Clear all

NCT04902443 2026-03-13

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Phase 1 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05470491 2026-02-25

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Phase 1/2 Recruiting

Other hematologic neoplasm

Acquired Immunodeficiency Syndrome, Hematologic Neoplasms

NCT07209917 2026-02-23

ASHA-Health II

Phase NA Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT04941274 2026-01-23

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Phase 1/2 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT02479698 2025-11-18

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Phase 2 Recruiting

Acquired Immunodeficiency Syndrome, Neoplasms, Carcinoma, Merkel Cell, Encephalitis, Viral

NCT04303117 2025-08-22

NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Phase 1/2 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections